Doramectin
Jump to navigation
Jump to search
| File:Doramectin.png | |
| File:Doramectin2.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Routes of administration | Injection and Topical |
| Physiological data | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Identifiers | |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C50H74O14 |
| Molar mass | 899.114 |
Doramectine (Dectomax) is a veterinary drug approved by the Food and Drug Administration (FDA) for the treatment of parasites such as gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites in cattle.[1]
It is available in 2 dosage forms: injection and a 5 mg/ml topical solution.
Doramectine is a derivative of ivermectin.
References
- ↑ Pfizer Animal Health. "DECTOMAX® Injectable." Last accessed July 14, 2007.
Categories:
- Articles with short description
- Pages with broken file links
- Drugs with non-standard legal status
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Anthelmintics